NEW YORK, NY / ACCESS Newswire / August 2, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Encompass Health Corporation ("Encompass" or the "Company") (NYSE:EHC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Encompass and certain of its officers and/or directors […]

NEW YORK CITY, NY / ACCESS Newswire / August 2, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Sable Offshore Corp. ("Sable" or the "Company") (NYSE:SOC).�� Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are

NEW YORK, NY / ACCESS Newswire / August 2, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Sable Offshore Corp. ("Sable" or the "Company") (NYSE:SOC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Sable and certain of its officers and/or directors

NEW YORK, NY / ACCESS Newswire / August 2, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Designer Brands Inc. ("Designer Brands" or the "Company") (NYSE:DBI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Designer Brands and certain of its officers

NEW YORK CITY, NY / ACCESS Newswire / August 2, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Lineage, Inc. ("Lineage" or the "Company") (NASDAQ:LINE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Lineage and certain of its officers and/or directors

NEW YORK, NY / ACCESS Newswire / August 2, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Altimmune, Inc. ("Altimmune" or the "Company") (NASDAQ:ALT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Altimmune and certain of its officers and/or directors have

NEW YORK CITY, NY / ACCESS Newswire / August 2, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Harrow, Inc. ("Harrow" or the "Company") (NASDAQ:HROW). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Harrow and certain of its officers and/or directors

NEW YORK CITY, NY / ACCESS Newswire / August 2, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Jasper Therapeutics, Inc. ("Jasper" or the "Company") (NASDAQ:JSPR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Jasper and certain of its officers and/or

NEW YORK, NY / ACCESS Newswire / August 2, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Necessity Retail REIT, Inc. ("Necessity Retail" or the "Company") (NASDAQ:RTL) who received shares of Global Net Lease, Inc. ("Global Net Lease") in connection with Global Net Lease’s acquisition of Necessity Retail on September 12,

NEW YORK CITY, NY / ACCESS Newswire / August 2, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Barnes & Noble Education, Inc. ("Barnes & Noble" or the "Company") (NYSE:BNED). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Barnes & Noble